Sotera Health (NASDAQ:SHC) Receives $15.92 Consensus PT from Brokerages

Shares of Sotera Health (NASDAQ:SHC) have received a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $15.92.

A number of brokerages have weighed in on SHC. Barclays lowered their price target on Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research report on Friday, February 28th. The Goldman Sachs Group began coverage on Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target on the stock.

Sotera Health Stock Performance

SHC opened at $11.90 on Wednesday. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.08. The firm has a market capitalization of $3.37 billion, a PE ratio of 47.60 and a beta of 1.92. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The business’s 50-day simple moving average is $12.94 and its 200 day simple moving average is $14.15.

Institutional Trading of Sotera Health

Several large investors have recently made changes to their positions in SHC. Victory Capital Management Inc. lifted its position in Sotera Health by 25.7% in the 3rd quarter. Victory Capital Management Inc. now owns 32,610 shares of the company’s stock valued at $545,000 after acquiring an additional 6,666 shares in the last quarter. Mutual of America Capital Management LLC increased its holdings in Sotera Health by 15.9% during the 3rd quarter. Mutual of America Capital Management LLC now owns 82,654 shares of the company’s stock worth $1,380,000 after purchasing an additional 11,342 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in Sotera Health by 19.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 35,929 shares of the company’s stock worth $600,000 after purchasing an additional 5,835 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Sotera Health by 18.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,348,917 shares of the company’s stock worth $22,527,000 after purchasing an additional 208,914 shares in the last quarter. Finally, Sessa Capital IM L.P. increased its holdings in Sotera Health by 46.5% during the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after purchasing an additional 2,000,000 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.